Hepatx Corporation

PALO ALTO, CA 94301

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $150K
First Award Date 09/15/17
Most Recent Award Date 09/15/17

Key Personnel

Last Name Name Awards Contact
CHAO MARK P CHAO 1

1 Award Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 09/15/17 - 03/31/18

Late-stage liver disease (LSLD) and is a contributing factor in more than 30,000 deaths per year in the US. Liver transplantation is the only disease-modifying treatment for LSLD, but this solution is impeded by a chronic shortage of available organs. HepaTx Corporation has licensed technology developed in the laboratory of Prof. Gary Peltz at S...